Northwest & Ethical Investments’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,500
Closed -$435K 566
2025
Q4
$435K Sell
2,500
-760
-23% -$139K 0.01% 406
2025
Q3
$462K Sell
3,260
-1,640
-33% -$201K 0.01% 406
2025
Q2
$488K Buy
4,900
+3,400
+227% +$260K 0.01% 396
2025
Q1
$114K Buy
1,500
+450
+43% +$34.4K ﹤0.01% 453
2024
Q4
$72.4K Hold
1,050
﹤0.01% 459
2024
Q3
$76.7K Sell
1,050
-550
-34% -$40.6K ﹤0.01% 475
2024
Q2
$107K Buy
+1,600
New +$62.1K ﹤0.01% 442

Other funds holding INSM

Northwest & Ethical Investments's INSM Position: Q1 2026 in Review

Northwest & Ethical Investments sold out of Insmed (INSM) in Q1 2026, closing a stake of 2,500 shares — an estimated $435K sold.

Northwest & Ethical Investments first reported a position in INSM in Q2 2024 and held it in 7 quarters. The position peaked at $488K in Q2 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Northwest & Ethical Investments reported no remaining Insmed position as of Q1 2026 after selling out during the quarter.
  • Northwest & Ethical Investments sold 2,500 Insmed shares in Q1 2026, an estimated $435K.
  • Northwest & Ethical Investments first reported a position in Insmed in Q2 2024 and held it in 7 quarters.
  • Northwest & Ethical Investments's Insmed position peaked at $488K in Q2 2025.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Northwest & Ethical Investments's 13F filing for Q1 2026, filed 14 May 2026.